Retrospective analysis of metastatic colorectal cancer based on clinical cancer registry data. Tumor biology, treatment, and outcome

被引:0
|
作者
Surovtsova, I. [1 ]
Kokh, D. [1 ]
Winzler, C. [1 ]
Morakis, P. [1 ]
机构
[1] Klin Landesregisterstelle, Canc Registry, Stuttgart, Germany
关键词
D O I
10.1016/j.annonc.2023.04.418
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-362
引用
收藏
页码:S141 / S141
页数:1
相关论文
共 50 条
  • [21] Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients' Outcome
    Galindo-Pumarino, Cristina
    Collado, Manuel
    Herrera, Mercedes
    Pena, Cristina
    CANCERS, 2021, 13 (05) : 1 - 29
  • [22] EARLY TUMOR SHRINKAGE AND CLINICAL OUTCOME IN METASTATIC COLORECTAL CANCER: ANALYSIS OF PREDICTIVE UTILITY IN THE CRYSTAL AND OPUS STUDIES
    Piessevaux, H.
    Van Cutsem, E.
    Bokemeyer, C.
    Schlichting, M.
    Heeger, S.
    Tejpar, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 37 - 37
  • [23] A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients
    Ogawa, Kohei
    Ueno, Takao
    Kato, Ken
    Nishitani, Hitoshi
    Akiyoshi, Kohei
    Iwasa, Satoru
    Nakajima, Takako Eguchi
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Hosokawa, Ayumu
    Sugiyama, Toshiro
    Shimada, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1020 - 1024
  • [24] Choice of first line treatment and survival in metastatic colorectal cancer - a retrospective analysis
    Oliveira, A.
    Bretes, L.
    Furtado, I.
    ANNALS OF ONCOLOGY, 2016, 27 : 48 - 48
  • [25] A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients
    Kohei Ogawa
    Takao Ueno
    Ken Kato
    Hitoshi Nishitani
    Kohei Akiyoshi
    Satoru Iwasa
    Takako Eguchi Nakajima
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Ayumu Hosokawa
    Toshiro Sugiyama
    Yasuhiro Shimada
    International Journal of Clinical Oncology, 2013, 18 : 1020 - 1024
  • [26] Retrospective analysis of dose intensity, toxicity, and clinical outcomes in 5-fluorouracil based regimens in the treatment of metastatic colorectal cancer
    Mulder, Karen E.
    Loree, Jonathan
    Ghosh, Sunita
    Spratlin, Jennifer L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
    Lai, Eleonora
    Liscia, Nicole
    Donisi, Clelia
    Mariani, Stefano
    Tolu, Simona
    Pretta, Andrea
    Persano, Mara
    Pinna, Giovanna
    Balconi, Francesca
    Pireddu, Annagrazia
    Impera, Valentino
    Dubois, Marco
    Migliari, Marco
    Spanu, Dario
    Saba, Giorgio
    Camera, Silvia
    Musio, Francesca
    Ziranu, Pina
    Puzzoni, Marco
    Demurtas, Laura
    Pusceddu, Valeria
    Dettori, Manuela
    Massa, Elena
    Atzori, Francesco
    Dessi, Mariele
    Astara, Giorgio
    Madeddu, Clelia
    Scartozzi, Mario
    CANCERS, 2020, 12 (05)
  • [28] Comparative Effectiveness of Prostate Cancer Treatment Options: Limitations of Retrospective Analysis of Cancer Registry Data
    Pearlstein, Kevin A.
    Basak, Ramsankar
    Chen, Ronald C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1053 - 1057
  • [29] Breast cancer stage at diagnosis, treatment, histology and survival using population-based cancer registry data.
    Ugnat, AM
    Xie, L
    Stern, H
    Viertelhausen, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S33 - S33
  • [30] Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients
    Riccardo Giampieri
    Lisa Salvatore
    Michela Del Prete
    Tiziana Prochilo
    Marco D’Anzeo
    Cristian Loretelli
    Fotios Loupakis
    Giuseppe Aprile
    Elena Maccaroni
    Kalliopi Andrikou
    Maristella Bianconi
    Alessandro Bittoni
    Luca Faloppi
    Laura Demurtas
    Rodolfo Montironi
    Marina Scarpelli
    Alfredo Falcone
    Alberto Zaniboni
    Mario Scartozzi
    Stefano Cascinu
    Scientific Reports, 6